$30M gets the company through initial readouts from the mCRC trial (and maybe first looks at AD trial as well...bonus!). Per Dr. J. that is when the other conversations will be "maturing." To me this capital availability is what bridges us to the liquidity event we are looking for, material partnership or BO. Financing doesn't look toxic. Looking forward to other insights and opinions.